Market Place
Sourcing Support
Fractyl Health Reports 2025 Financial Results And Updates
24 Mar 2026 //
GLOBENEWSWIRE
Fractyl Health Reports 2025 Results and Business Updates
17 Mar 2026 //
GLOBENEWSWIRE
Fractyl Health Names Lara Smith Weber as CFO for Commercial Stage
06 Jan 2026 //
GLOBENEWSWIRE
Fractyl Health Calls Tranche A Warrants Post Milestone
15 Dec 2025 //
GLOBENEWSWIRE
Fractyl Health To Join 8Th Evercore Healthcare Conference
01 Dec 2025 //
GLOBENEWSWIRE
Fractyl Health Reports Third Quarter 2025 Results
12 Nov 2025 //
GLOBENEWSWIRE
Fractyl Health To Release Q3 2025 Financials & Business Results
05 Nov 2025 //
GLOBENEWSWIRE
Fractyl Health Data Shows Revita Maintains Weight Loss Post GLP-1
26 Sep 2025 //
GLOBENEWSWIRE
Fractyl Health Prices $60M Common Stock Offering
26 Sep 2025 //
GLOBENEWSWIRE
Fractyl Health`s Q2 2025 Financial Results and Business Updates
12 Aug 2025 //
GLOBENEWSWIRE
Fractyl Health Sets Price for $20 M Public Offering of Shares
06 Aug 2025 //
GLOBENEWSWIRE
Fractyl Health to Report Q2 2025 Results, Business Updates
06 Aug 2025 //
GLOBENEWSWIRE
Fractyl Reports 2-Year Revita Outcomes With Weight Loss
05 Aug 2025 //
GLOBENEWSWIRE
Fractyl Health’s REVEAL-1 Shows Weight Loss After GLP-1 Stop
23 Jun 2025 //
GLOBENEWSWIRE
Fractyl Health strengthens IP leadership with 2 new US Patents
18 Jun 2025 //
GLOBENEWSWIRE
Fractyl Health and Bariendo Sign Letter of Intent
04 Jun 2025 //
GLOBENEWSWIRE
Fractyl Health Announces Q1 2025 Financial Results and Updates
13 May 2025 //
GLOBENEWSWIRE
Fractyl Health to Report Q1 2025 Results on May 13, 2025
06 May 2025 //
GLOBENEWSWIRE
Fractyl Health Reports Positive Data on Revita® for Weight Regain
01 Apr 2025 //
GLOBENEWSWIRE
Fractyl Reports Q4, Full-Year 2024 Financials, Business Update
03 Mar 2025 //
GLOBENEWSWIRE
Fractyl Health to Report Q4 and Full Year 2024 Financial Results
24 Feb 2025 //
GLOBENEWSWIRE
Fractyl Shows Weight Maintenance After GLP-1 Stop With Revita
13 Jan 2025 //
GLOBENEWSWIRE
Fractyl Health to Participate in the Upcoming December Conferences
26 Nov 2024 //
GLOBENEWSWIRE
Fractyl Health Reports Q3 2024 Financial Results & Updates
12 Nov 2024 //
GLOBENEWSWIRE
Fractyl Health Shows Durable Weight Loss at ObesityWeek® 2024
04 Nov 2024 //
GLOBENEWSWIRE
Fractyl Health to Report Q3 2024 Results on Nov 12, 2024
29 Oct 2024 //
GLOBENEWSWIRE
Fractyl Health Presents Weight Maintenance Data at ObesityWeek
28 Oct 2024 //
GLOBENEWSWIRE
Fractyl Health to Participate in Upcoming September Investor Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Fractyl Health Reports Q2 2024 Financial Results And Business Updates
14 Aug 2024 //
GLOBENEWSWIRE
Fractyl Health Announces Clinical Results From German Registry
08 Aug 2024 //
GLOBENEWSWIRE
Fractyl Health To Report Q2 2024 Results And Updates On August 14
07 Aug 2024 //
GLOBENEWSWIRE
Fractyl Health`s Revita Gets FDA Breakthrough Device Designation
30 Jul 2024 //
GLOBENEWSWIRE
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
25 Jun 2024 //
GLOBENEWSWIRE
Fractyl Health advances Weight Maintenance Pipeline and business updates.
24 Jun 2024 //
GLOBENEWSWIRE
Fractyl Health Preclinical Data Rejuva® GLP-1 Therapy ADA 84th Session
23 Jun 2024 //
GLOBENEWSWIRE
Fractyl Presents Rejuva® Obesity Preclinical Data At ADA 2024
29 May 2024 //
GLOBENEWSWIRE
Fractyl Presents Revita German Registry Update For Advanced T2D
13 May 2024 //
GLOBENEWSWIRE
Fractyl Health Q1 2024 Financials, Business Updates
13 May 2024 //
GLOBENEWSWIRE
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
08 May 2024 //
GLOBENEWSWIRE
Fractyl Q1 2024 Results And Updates On May 13
07 May 2024 //
GLOBENEWSWIRE
Fractyl: Presentations At DDW 2024, DDG On Type 2 Diabetes Treatments
30 Apr 2024 //
GLOBENEWSWIRE
Fractyl Health Appoints Kimber as COO & Conducts Two Pivotal Studies for Revita
02 Apr 2024 //
GLOBENEWSWIRE
Fractyl Health Receives FDA IDE Approval for the Revita
01 Apr 2024 //
GLOBENEWSWIRE
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results
01 Apr 2024 //
GLOBENEWSWIRE
Fractyl Health Announces New Results From Its Rejuva® Platform
12 Mar 2024 //
GLOBENEWSWIRE
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform
12 Mar 2024 //
GLOBENEWSWIRE
Fractyl Health Appoints Samuel Conaway to Its Board of Directors
20 Feb 2024 //
GLOBENEWSWIRE
Fractyl Health raises $110 mln in US IPO
02 Feb 2024 //
REUTERS
Fractyl Health targets up to $762 mln valuation in US IPO
02 Feb 2024 //
REUTERS
Fractyl Health valued at $654.6 mln in tepid debut
02 Feb 2024 //
REUTERS
Alto, Fractyl head to public markets with IPOs north of $100M
02 Feb 2024 //
FIERCE BIOTECH
Fractyl Health Announces Pricing of Initial Public Offering
01 Feb 2024 //
GLOBENEWSWIRE
Fractyl Health Announces New Pooled Analysis From Revita® Clinical Studies
14 Dec 2023 //
GLOBENEWSWIRE
Fractyl Health to Present Pioneering Data on Revita® and Rejuva® Programs
28 Sep 2023 //
BUSINESSWIRE
Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer
14 Sep 2023 //
BUSINESSWIRE
Fractyl Health Reports Durable Improvement in Glucose Control & Weight Loss
26 Jun 2023 //
BUSINESSWIRE
Fractyl Health Announces Commercial Availability of Revita in Germany
07 Feb 2023 //
BUSINESSWIRE
Fractyl Health Announced Positive Proof-of-Concept Data of GLP-1 Gene Therapy
05 Dec 2022 //
BUSINESSWIRE
Fractyl Health Presents New Mechanistic Data on Revita® DMR in Type 2 Diabetes
22 May 2022 //
BUSINESSWIRE
Fractyl Health Announces FDA IDE Approval to Begin Revitalize-2 Pivotal in T2D
04 Apr 2022 //
BUSINESSWIRE
